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INTRODUCTION 
It is quite well established that deficiency of vitamin may cause 
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neurological complications ’ . It is not widely accepted that deficiency of 
folic acid may also cause neurological complications. In fact, aggravation of the 
neurological complications of patients with pernicious anemia treated with folic 
acid has been reported and suggests that the administration of this vitamin 
may be harmful to the nervous system under some circumstances. However, some 
recent studies in epileptic and psychiatric patients have raised some interesting 
and unanswered questions about the role of folic acid and the significance of 
folic acid deficiency for nervous system function. 
There is evidence from studies in epileptic patients of an association of 
3 1A- 20 21 
mental illness with low folate levels in serum, red cells and CSF.’ ’ 5 
There have been reports of improvement in mental state in epileptics with folate 
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deficiency when treated with folate. ’ Several studies and case reports have 
suggested a relationship between folate deficiency and nervous system function 
in a non-epileptic population. But, there is also evidence 
against any role for folate deficiency in the development of psychiatric and 
, . , -i . . . 10,11,15,23 
neurological complications. 
Thus, while some of the studies in epileptics and non-epileptics suggest 
that folic acid deficiency may be harmful to the central nervous system, the 
evidence is conflicting in part, and the significance of folic acid deficiency 
for the nervous system remains uncertain. In Brain's Diseases of the Nervous 
System for example, it is suggested that, "estimation of the serum folate should 
be carried out in cases of unexplained polyneuropathy, myelopathy and dementia, 
although the exact role of folate deficiency in these disorders remains to be 
determined." That folic acid must be important in central nervous system 
metabolism is suggested by the fact that the CSF folate level is normally three 
g 
times that in the serum. 
There have been no studies of the incidence of neurological or psychiatric 

disorders in patients with folic acid deficiency. In this study I hoped to 
learn whether there is a higher incidence of neurologic disease in patients 




The subjects were 45 in-patients at the Yale-New Haven Medical Center 
and at the West Haven Veterans Administration Hospital. Thirty-four of these 
patients were seen at Yale-New Haven and 11 were seen at the Veterans Hospital. 
The majority of the patients were on the general medical service. None were 
on the neurology service in order to limit bias as much as possible in the 
selection of patients for folate determination. There were 33 males (including 
all 11 from the Veterans Hospital) and 12 females. 
The ages of the patients with low serum folic acid levels ranged from 
28 to 94 with a mean age of 55.5 (SEM + 3.5). The ages in the control group 
with normal folate ranged from 30 to 81 with a mean age of 56.8 (SEM + 2.9). 
There were 18 males and 6 females in the low folate group and 15 males and 
6 females in the control group. 
There were 20 alcoholic patients, 12 of whom had low serum folic acid 
levels. A patient was considered alcoholic if he had biopsy proven Laennec's 
cirrhosis, a clinical diagnosis of cirrhosis and/or gave a history of constant 
alcohol consumption causing a loss of time from work or disruption of home 
1 ife. 
Procedure 
Patients with folic acid deficiency were selected in the clinical 
microscopy laboratory where all serum folic acid determinations for the 
Yale-New Haven Hospital and West Haven Veterans Administration Hospital are 
performed (Dr. Barnes, Clinical Microscopy, Memorial Unit). Although serum 
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folic acid concentrations of <5ng/ml are considered low in this laboratory, 
only patients with levels < 3ng/ml (severe deficiency) were included in the 
deficient group in order to avoid all doubts. The observers had no prior 
knowledge of the physical or mental state of these patients. During the 
period of this study, all patients on whom a CBC was ordered had RBC indices per 
formed. Folate levels were performed by Dr. Barnes routinely on all patients 
with macrocytic indices whether or not the physician in charge had requested 
folate values. In a minority of the cases serum folate values had been 
specifically requested as an index of the nutritional state of the patient 
(most of these were from the Veterans Hospital). As best as we could determine 
in no case did the neurologic condition of the patient provide the reason for 
estimating serum folic acid. The basic criterion for the inclusion of 
patients in the control group was a serum folic acid level > 6.9ng/ml. 
Once the level was determined, the patient's chart was reviewed. As far 
as possible patients were chosen for the control group because of similar 
age, sex and basic disease processes as those patients with chemical evidence 
of folic acid deficiency, but otherwise the observers had no direct know¬ 
ledge of the physical or mental state of these patients. Serum folate was 
determined by the Lactobacillus casei method and serum vitamin B^ by the 
Co~^ method. 
Each patient had a mental status and neurological examination. In 
the mental status examination attention was paid to behavior, mood, speech, 
thought content, memory, concentration, intelligence and orientation. 
Memory was evaluated by questions about recent, remote and immediate incidents. 
Immediate memory was checked by a patient's ability to repeat 7 digits 
forward and 3 digits backward. Patients who had attended high school were 
asked to subtract 7 serially from 100 and others to subtract 3 serially. 
The patient's fund of general information was estimated by questions geared 
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to his educational level and interests (e.g. name of the President and 
his immediate predecessors, 5 large cities in the U.S.). Patients were asked 
to interpret proverbs (e.g. the early bird catches the worm) and similarities 
(e.g. how are an orange and an apple alike ). Orientation was judged by 
the patient's ability to know who he was, where he was and the day, month and 
year. Mental status was not graded except normal or abnormal on the basis 
of the examiner's experience. 
In the neurological examination special emphasis was placed on the 
possibility of subacute combined degeneration of the spinal cord and peripheral 
neuropathy. Clinical signs of injury to the posterior column tested were 
loss of position sense in the toes, impairment of ability to recognize vibration 
over the legs and loss of two point discrimination. Babinski signs were looked 
for as indication of degeneration of the pyramidal tracts. Pinprick sensation 
was tested in the hands and feet and the biceps, triceps, patellar and ankle 
reflexes were examined. In each case where there was even a suspicion of 
any abnormal findings the patient was also examined by Dr. Jonathan Pincus, 
Associate Professor of Neurology, or Dr. E.H. Reynolds, Visiting Assistant 
Professor of Neurology. Neither Dr. Pincus nor Dr. Reynolds was aware of the 
patient's folate level at the time of examination. For purposes of this 
study all abnormal sensory findings were classified together as neuropathy. 
It is difficult on the basis of physical examination alone to distinguish 
position sense loss which occurs as a result of peripheral neuropathy from 
that which results from posterior column damage. It is even more difficult 
to assess posterior column function in the presence of mild neuropathy. 
Furthermore, it is not unusual in patients over 50 years of age to find minor 
changes in the appreciation of vibratory sensation in the lower extremities 
and the average age of patients in this study was about 55. For these reasons 
I have not attempted to distinguish posterior column loss from peripheral 
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neuropathy in cases where physical signs were compatible with either or both, 
and I regarded position sense loss as evidence of peripheral neuropathy for 
the purposes of this study. If position and vibration sense were severely 
impaired in a patient whose pinprick sensation and deep tendon reflexes were 
preserved, one could be more certain of posterior column damage. However, 
none of the patients in this study had such clear cut evidence. 
In evaluating the mental status of a patient, it is sometimes difficult 
to distinguish reactive depression from mild dementia. Indeed, both often 
occur simultaneously. For the purposes of this study, we have included the 
5 patients (2 with folate deficiency and 3 controls) who showed disabling 
apathy and depression in the category of organic brain syndrome although 
other tests of intellectual functioning were not greatly disordered. 
RESULTS 
The patients with folic acid deficiency were compared with controls 
(Table 1). There were 24 patients in the low folate group of whom 17 had 
an organic brain syndrome (OBS); 3 had cerebellar dysfunction; 14 had neuro¬ 
pathy; 5 demonstrated a Babinski sign and 2 were entirely normal. In the 
control group, there were 21 patients. Of these, 8 had an OBS; 1 had cerebellar 
dysfunction; 7 had neuropathy ; none demonstrated the Babinski sign and 
8 were entirely normal. The difference between these groups is statistically 
significant in the findings of OBS (p < .03) and of the Babinski sign (p <.03 ). 
The incidence of neuropathy was also considerably higher in the folate 
deficient group. 
To eliminate the factor of severe anemia, all patients with a hemoglobin 
(Hb) of less than 10 were eliminated (Table 2). There were 31 patients left, 
12 with low folates and 19 with normal folates. In the low folate group, 
8 had an 0BS“ 1 had cerebellar dysfunction* 8 had neuropathy ; 3 demonstrated 
the Babinski sign and only one was entirely normal. In the normal folate group, 
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7 had an OBS; 1 had cerebellar dysfunction; 6 had neuropathy; none demonstrated 
a Babinski sign and 7 were entirely normal. The incidence of the Babinski 
sign is significantly greater in the low folate group (p < .025). The 
incidence of other signs was also considerably higher in the low folate group; 
OBS (66.7%) and neuropathy (66.7%) as compared to the normal folate group 
where the incidence was 36.8% and 31.6% respectively, but these differences 
just fell short of statistical significance. 
The low folate group was then divided according to Hb content into 
a group with Hb < 10 (severe anemia) and a group with Hb > 10 (Table 3). 
There were 12 anemic low folate patients of whom 9 had an OBS; 2 had cerebellar 
dysfunction; 6 had neuropathy and 2 demonstrated a Babinski sign. In the 
non-anemic low folate group of 12 patients; 8 had an OBS; 1 had cerebellar 
dysfunction; 8 had neuropathy and 3 demonstrated a Babinski sign. In each 
group there was only one patient without any abnormal findings. The incidence 
of neurological complications is thus essentially the same in folate deficient 
patients whether or not they are anemic. 
Alcoholic patients with low and normal serum folates were compared 
(Table 4). There were 12 patients in the low folate group of whom 8 had 
an OBS; 3 had cerebellar dysfunction; 10 had neuropathy; 1 had a Babinski 
sign and none were entirely normal. In the normal folate group there were 
8 alcoholics of whom 3 had an OBS; 1 had cerebellar dysfunction; 4 had neuro¬ 
pathy; none had a Babinski sign and 2 were entirely normal. Though the 
difference between these groups is not statistically significant at the 5% 
level, the frequency of all abnormal neurologic signs was considerably higher 
in the low folate group. 
Non-alcoholic patients were then studied (Table 5). In the low folate 
group 9 out of 12 had an OBS; none had cerebellar dysfunction; 4 had neuro¬ 
pathy ; 4 demonstrated a Babinski sign and 2 had no abnormal findings. 
In the normal folate group 5 of 13 had an OBS; none had cerebellar dysfunction; 
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3 had neuropathy; none had a Babinski sign and 6 had no abnormal findings. 
The more frequent finding of a Babinski sign in the low folate group was 
statistically significant (p < .025), and the incidence of an OBS was much 
higher in this group also ( p < .07). 
The folate deficient patients were divided into alcoholic and non-alcoholic 
groups (Table 6). In the alcoholic group, 8 of 12 had an OBS; 3 had cerebellar 
dysfunction and 1$ had neuropathy. In the 12 non-alcoholics, the incidence 
of OBS was similar to that in alcoholics but none had cerebellar dysfunction 
and only 4 had neuropathy. Two of the non-alcoholics were entirely normal 
while all the alcoholics had abnormal findings. Thus, the incidence of 
cerebellar dysfunction and neuropathy were significantly higher in the 
alcoholic group. 
Finally, only those patients without any condition that is ordinarily 
associated with neurological signs were studied (Table 7). Excluded were 
patients with alcoholism,diabetes, renal disease, metastatic carcinoma, 
malnutrition and those over 80 years of age. In the low folate group, 4 of 5 
had abnormal findings. In the normal folate group of 8 patients, one had an 
abnormal examination and 2 had only the finding of depression in the absence 
of other signs of intellectual impairment. If these 2 patients are not 
considered abnormal, the incidence of abnormal findings was significantly 




The initial comparison of patients with a folic acid deficiency and those 
without such a deficiency shows a significant difference in the incidence of 
OBS and of a Babinski reflex. The finding of a neuropathy is much more common 
in those patients with a folic acid deficiency but not significantly so. 
The finding of cerebellar dysfunction is not markedly different in the two groups. 
This suggests that folate deficiency may lead to OBS, pyramidal tract damage 
and neuropathy. However, this association does not prove a causal relationship. 
Factors such as age, sex and other conditions must also be considered. In 
this study there was a close correlation in the age and sex of the two groups. 
The two most common associated conditions were anemia and alcoholism and it 
is clear that their role must be evaluated. 
The patients with a folic acid deficiency were considerably more anemic 
than those in the normal folate control group. This was to be expected since 
folate deficiency is a known cause of megaloblastic anemia^. In an attempt 
to assess the role that might be played by anemia in the development of neurolo¬ 
gical signs, those patients with Hb> 10 were divided into normal and folate 
deficient groups and compared (Table 2). Once again there was a statistically 
significant difference in the finding of a Babinski reflex in the low folate group 
(leading to the assumption that the low folate was a more critical determinant 
of this finding than anemia). OBS and neuropathy were twice as prevalent in 
the low folate group but this just fell short of statistical significance. 
Thus, it would appear that folate deficiency may be a critical determinant 
in the development of a neurological deficit. 
To evaluate further the role played by anemia in the development of 
neurologic signs, the patients with folate deficiency were divided into those 
with Hb< 10 and Hb >10 (Table 3). There were 12 in each group. If, as 
postulated earlier, low folate is a more critical determinant in the develop¬ 
ment of neurological deficits than is severe anemia, there should have been no 
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significant difference between the two groups. This hypothesis is indeed borne 
out. The finding of a Babinski reflex, which had been statistically significant 
when comparing a low folate group with a normal folate group (Tables 1 and 2), 
is nearly the same in the anemic and non-anemic groups of folate deficient 
patients. Similarly, OBS was seen in 9/12, 75% of the anemic group and 
8/12, 66.7% of the non-anemic group. The incidence of neuropathy was 6/12 
(50%) in the anemic folate deficient patients and 8/12 (66.7%) in the non-anemic 
ones. This very close correlation in the incidence of abnormalities between 
these two groups indicates that anemia per se is not a critical determinant of 
any of the neurological findings even though anemia is more prevalent in the 
folate deficient population. 
It is clear that the role played by alcohol must be studied since alcoholism 
and folic acid deficiency frequently accompany each other. In this study 
50% (12/24) of the low folate patients were alcoholics as were 38.4% (8/21) 
of the normal folate group. 
The first comparison made is between alcoholics with folate deficiency and 
alcoholics with normal serum folate (Table 4). There was a greater incidence 
of all neurological deficits in the folate deficient group of alcoholics 
but the difference between the two groups did not turn out to be statistically 
significant at p < .05, probably because of the small size of the population 
studied. This trend gives further evidence supporting the role of folic acid 
deficiency in the development of these findings. However, it could be argued 
that folate deficient alcoholics were in worse general condition than alcoholics 
with normal folates. 
To eliminate the role played by alcoholism as a factor in neurologic 
deterioration, non-alcoholic patients were grouped by folate level (Table 5). 
The Babinski sign was found significantly more frequently in the low folate 
group. This further supports the belief that folic acid deficiency is a key 
factor in the development of pyramidal damage. The finding of an OBS was 
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considerably higher in the low folate group (9/12) than the normal folate 
group (5/13) but the size of the sample supported this only at the 93% 
level of probability. The strong trend towards an increased incidence of OBS 
in the low folate group in an alcoholic population (Table 4) and the low folate 
group in a non-alcoholic population (Table 5) further supports the concept that 
folic acid deficiency is an important factor in the development of this 
finding. The incidence of neuropathy in non-alcoholics was low irrespective of 
folate level. It occurred in 4 of 12 with low folates and 3 of 13 with normal 
folates. However, neuropathy was quite common amongst alcoholics, folate 
deficient or not, though somewhat more so in the low folate group (83% vs. 50%). 
These results imply that the trend towards an increased incidence of neuro¬ 
pathy in a folate deficient population when compared to a normal folate population 
is more a function of alcoholism than of the folic acid deficiency alone* 
The importance of alcoholism in the development of cerebellar dysfunction is 
indicated by the absence of cerebellar findings in non-alcoholics, folate 
deficient or not. 
Support for these conclusions is provided in Table 6 where the folate 
deficient alcoholics are compared with folate deficient non-alcoholics. There 
were 12 patients in each group. If the development of neurological abnormalities 
is determined primarily by folic acid deficiency then one would expect a close 
correlation between the incidence of neurologic signs in the two groups. The 
incidence of OBS was essentially the same in the two groups but there was consid¬ 
erably greater incidence of cerebellar dysfunction and neuropathy in alcoholic 
patients than non-alcoholic patients. The somewhat increased incidence of a 
Babinski reflex in the non-alcoholic patients with a low folate than the alcoho¬ 
lic patients with low folate is not significant. It is not inconsistent with the 
conclusion that folate deficiency may cause pyramidal tract dysfunction and 
that alcoholism is not a critical factor in the development of this finding. 
-10- 
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As previously mentioned, the association between folate 
deficiency and certain neurological abnormalities does not prove a 
causal relationship. Other factors associated with low folate could cause 
neurological signs and some of these factors were examined in detail 
in this study. Certainly, the multiple nutritional deficiencies 
that may be seen in conjunction with folate deficiency must be considered. 
Vitamin B ^ is one °f these factors and in this study almost all 
patients had normal levels. In the low folate group, 18 of 20 patients 
who had serum vitamin determinations had normal levels. One patient 
had a slightly depressed level and one had a very low level with a 
normal Schilling test. In the control group, all 17 patients who had 
vitamin B^ determinations had normal levels. 
To eliminate as many potential etiologic factors as possible, 
a group of patients whose conditions are not usually associated with 
neurological abnormalities were compared with respect to folate levels 
(Table 7). If we exclude for the moment the isolated finding of 
depression in the absence of other evidence of organic mental impairment, 
only 1 of 8 patients with normal folate levels was abnormal; on the 
other hand, 4 of 5 folate deficient patients were abnormal. This 
difference is highly significant (p < .014). This lends further evidence 
to a foie for folate deficiency in the development of neurological 
findings but does not prove the point; for this would require evidence 
of remission of the neurological signs after treatment with folate alone. 
In this study the abnormal sensory findings on neurological exam 
were categorized as neuropathy. The clinical picture was often a mixture 
of signs of the peripheral nerve and the spinal cord. Some of the signs 
may have been due to peripheral nerve involvement alone and some to involvement 
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of the spinal cord as well. This distinction is difficult to make 
and I chose to include all sensory impairment in the category of peripheral 
neuropathy. Thus, this study does not rule out a possible role of folic 
acid deficiency in the development of posterior column dysfunction. 
In addition to this study, several other investigators have attempted 
to assess the role played by folic acid deficiency in the development 
of neuropsychiatric disease. These studies provided the background 
for this work. 
a) Studies in Epileptic Patients 
Reynolds (1970) has reviewed the evidence from studies of serum, red 
cell and CSF folate levels indicating that the three major drugs in the 
treatment of epilepsy (phenobarbital, diphenylhydantoin and primidone) 
may affect folate metabolism in the majority of epileptic patients. 
Reynolds et al (1966) suggested that drug induced folate deficiency may 
contribute to psychiatric and neurological complications in these patients. 
The following evidence supports this hypothesis: 
1) Association of mental illness with low folate levels in serum, 
red cells and CSF - 
Reynolds, Preece and Chanarin reported that serum folate levels 
were lower in epileptic patients with various abnormal mental states 
than in those with normal mental states, though this was statistically 
significant only in patients with dementia and schizophrenia-like 
psychoses. 
Snaith, Mehta and Raby found epileptic patients with mental illness 
had significantly lower serum folate levels than epileptic patients without 




Callaghan, Mitchell and Cotter found much lower serum folate levels 
in psychotic epileptic patients than in non-psychotic epileptics. 
Preece, Reynolds and Johnson reported a significant lowering of serum 
and red cell folate in epileptic patients with psychiatric illness, as 
compared with controls and epileptic patients with normal mentat states. 
Significantly lower CSF folate levels were found by Reynolds, Preece 
and Chanarin in epileptic patients with psychiatric illness than in epileptic 
patients with normal mental states. 
2) Results of treatment 
In a study of 26 chronic epileptic patients with folic acid deficiency 
due to anticonvulsant drugs, Reynolds (1967) noted that the mental state 
improved in 22 when treated with folic acid. The improvement took the form 
of increased drive and initiative, speed of cerebration, alertness, concen¬ 
tration, self-confidence and independence and sociability. Favorable 
changes in mood and behavior were also noted. 
In a 1970 study Neubauer treated 50 folate deficient epileptic children 
with a combination of folic acid and vitamin Improvement in mental 
condition occurred from 5-8 weeks after beginning treatment in some of the 
younger children and it was recommended that both folic acid and vitamin B^ 
be given as soon as a patient is started on anticonvulsant drugs to prevent 
mental deterioration. 
On the other hand, the following evidence has been offered against 
the hypothesis that folate deficiency contributes to psychiatric and neurolo¬ 
gical complications in epileptic patients: 
Jensen and Olesen (1969) studied 34 patients suffering from epilepsy 
and treated with anticonvulsant drugs. Although 91% of these patients had 
subnormal serum folate levels, they reported that only one of these patients 
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had subnormal whole blood folate levels. They concluded that in spite of 
the subnormal serum folate levels, no folate deficiency state was found. 
These results are somewhat difficult to interpret because no controls were 
included. 
Jensen and Olesen (1970) also did a double blind study in which 24 
of their patients with subnormal serum folate were treated with folic acid. 
They evaluated the effect of the vitamin on the mental state, fit frequency, 
hematological condition and serum levels of diphenylhydantoin and phenobar- 
bital. With the exception of a slight decrease in serum diphenylhydantoin 
levels no changes that could be ascribed to folic acid treatment could be 
found. They concluded that no objective evidence has been reported for 
a causal relationship between folate deficiency and neuropsychiatric 
disorders. These results are also subject to question since all the patients 
were demented and the course of treatment did not include vitamin B-^j 
the importance of which has been emphasized by both Reynolds and Neubauer. 
Weckman and Lehtovaara also question any relationship between anti¬ 
convulsant drugs, folate metabolism and psychiatric illness, since they found 
no significant difference in CSF folate levels between treated epileptic, 
untreated epileptic and neurological control patients. However, they are 
the only authors who have not found lowering of serum folate values in 
epileptic patients and their control CSF values are much lower than in 
other studies. 
Ralston, Snaith and Hinly confirmed reports that anticonvulsants lowered 
serum folate levels and probably deplete body stores of folic acid. In a 
double blind trial of folic acid for 3 months in long tern epileptic patients 
with serum folates less than 3 ng/ml no significant changes in behavior 
were found. However, they concluded that they hadn't yet repleted body stores 
of folic acid after the three months of therapy. 
-14- 
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b) Studies in non-epileptic patients 
In 1967, Carney measured serum folates on 423 psychiatric in-patients. 
He found that there were significantly more patients with values less than 
2 ng/ml (low folate) than controls. The most striking associations with low serum 
folate were chronicity of illness, a history of medication and the predominance 
of certain diagnoses- namely epilepsy, endogenous depression and organic 
brain syndrome. He concluded that folate deficiency appeared common enough 
in the mentally ill to justify carrying out serum folate as a routine 
admission procedure and advised treatment with folic acid and vitamin 
in patients with subnormal serum folate in the hope of attaining mental as 
well as physical improvement. In a follow-up study, low folate patients with 
endogenous depression, schizophrenia and organic psychoses who were treated with 
folic acid were discharged more quickly and were in a better clinical state 
at discharge than those who had not received folate. Low folate patients 
with other diagnoses failed to show these improvements when given the vitamin . 
Grant, Hoffbrand and Wells examined 7 patients in a neurological hospital 
with megaloblastic hemopoiesis and folate deficiency. Three of them had a 
peripheral neuropathy and one of them and possibly a second had early spinal 
cord involvement. Marked subjective and some objective neurological improvement 
occurred with folic acid therapy. The remaining four patients had spastic 
paraplegias of unknown etiology and folic acid did not affect their neurological 
status. They did not find this surprising even if there was a link between the 
neurological disability and folate deficiency since once spinal cord disease 
is well established it is resistant to therapy. 
Strachan and Henderson described two patients with megaloblastic anemia 
who also presented with advanced dementia. They were treated with folic acid 
and in addition to curing the anemia, a marked improvement in the mental state 
was noted in one and a complete return to normality was seen in the second. 
-15- 
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Pincus, Reynolds, and Glaser have also presented a case of a woman 
with severe folate deficiency and clinical picture of megaloblastic anemia, 
dementia, impairment of posterior column functions, absent reflexes and 
bilateral Babinski signs. All these abnormalities resolved on folic acid therapy. 
Ahmed has very recently reported a case of a woman with numbness in her 
feet and legs, marked weakness in the legs and absent vibratory and position 
sense in the legs. Romberg's sign was positive and Babinski's sign was 
present bilaterally. She had a hemoglobin of 8.2 and an MCV of 117 with a 
serum folate of 0.6 ng/ml. She was started on folate and physical improvement 
was reported as remarkable. Her legs became stronger, the numbness disappeared 
and no sensory loss was detected but the plantars remained upgoing. 
Several patients with three separate inborn errors of folate metabolism 
have been studied by Arakawa. The clinical features he observed were mental 
retardation and abnormalities on electroencephalogram and pneumoencephalogram. 
One of the important methodologic questions which can be raised about 
many studies of folate deficiency, including this one, relates to the adequacy 
of serum folic acid as an index of CNS folate levels. It is not clear how the 
serum level reflects the actual level in the CNS. Not all persons with folic 
acid deficiency as determined by serum values develop neurologic complications. 
There does not appear to be any exact correlation between the hematologic state 
and neurological disease. In this study 9 patients with markedly lowered 
serum folate levels had bone marrow examinations. Only 6 of these showed mega¬ 
loblastic changes. If megaloblastosis was an index of the central folate 
stores, one would expect a high correlation with severe neurologic impair¬ 
ment. Yet, of the 6 with megaloblastic marrows, 2 had completely normal neuro¬ 
logic examinations, and 2 had evidence of OBS only. These observations are not 
surprising in light of what is known about vitamin deficiency. Neurologic 
symptoms do not develop in all patients with pernicious anemia. For unknown 
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reasons, some patients develop subacute combined degeneration before the onset 
of anemia, while others show no evidence of neurologic disease, even after 
9 
protracted and severe anemia. Reynolds (1967) has suggested that genetic, 
anatomical, psychosocial, personality and other factors of an unknown nature 
may determine the form of response to a common biochemical stress to the ner¬ 
vous system. However complicated such factors may be, it also seems likely that 
serum folate and/or the associated hematologic changes of folate deficiency pro^ 
vide only a rough guide to the actual state of the central nervous system. 
Administration of folic acid, for example, raises serum but not necessarily CSF 
levels (Levitt, et al and B. Gallagher, unpublished data). It seems likely 
on the basis of all these studies that folic acid is important in normal neural 
functioning but many questions remain to be answered about the role of folic 
acid in the nervous system. 
SUMMARY 
Twenty-four patients with a folic acid deficiency were studied. These 
patients all had serum folate values less than 3 ng/ml. They were compared 
with normal folate controls which consisted of a group of 21 patients. These 
patients all had serum folate values greater than 6.9 ng/ml. 
A comparison was made between the low folate group and the normal folate 
control group. In the low folate group 17/24 had an organic brain syndrome 
3/24 had cerebellar dysfunction, 4/24 had a neuropathy and 5/24 demonstrated 
a Babinski sign. In the normal folate group 8/21 had an OBS, 1/21 had cerebellar 
dysfunction, 7/21 had a neuropathy and none had a Babinski sign. The difference 
between the two groups is statistically significant at p < .03 in the finding 
of an organic brain syndrome and a Babinski sign. The incidence of neuropathy 
was considerably higher in the low folate group. There was little difference 
in the two groups in the finding of cerebellar dysfunction. 
The patients with a folic acid deficiency were considerably more anemic 
than the normal folate control group. Only 50% (12/24) of the folate deficient 
-17- 

patients had a Hb> 10 while 90.5% (19/21) of the normal folate group had 
a Hb > 10. Comparisons were made to determine the role played by anemia in the 
development of neurological or psychiatric disorders. It was determined that 
the anemia did not play a significant role. 
In this study 50% (12/24) of the low folate patients were alcoholics 
and 38.4% (8/21) of the normal folate group were alcoholics. Comparisons 
were made to delineate the role played by alcohol in the development of neuro¬ 
psychiatric problems in patients with folic acid deficiency. It was determined 
that the findings of organic brain syndrome, and of a Babinski sign were primarily 
on the basis of folate deficiency while the finding of a neuropathy was in large 
part due to alcoholism. Cerebellar dysfunction, although not a significant 
finding, is also largely a function of alcoholism. 
It is clear that many questions remain to be answered about the role of 
folic acid in the nervous system and it is hoped that larger studies with 
long term follow-up will be done. 
-18- 
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TABLE 1: Comparison of Findings in Low Folate vs. Normal Folate Control Group 






OBS* * 7/24 8/21 K2 =4.96 
70.8% 39.0% p < .03 
Cerebellar 
Dys function 3/24 1/21 N. S.** 
12.5% 4.8% 








Babinski 5/24 0/21 M2 = 4.79 
20.8% 0% p < .03 
OBS = Organic Brain Syndrome 
■*N.S. = Not significant 

TABLE 2: Comparison of Findings in Patients with Hb > 10 and Low Folate vs. 





Low Folate Normal Folate Statistical 
Significance 
OBS 8/12 7/19 X2 = 2.99 
66.7% 36.8% P < .09 
Cerebellar 1/12 1/19 N.S. 
Dys function 8.3% 
. .. ... . 
5.3% 
Neuropathy 8/12 6/19 X2 = 3.71 
66.7% 31.6% p < .06 
Babinski 3/12 0/19 X2 = 5.0 
25% 
_ 
0 p = .025 

TABLE 3: Comparison of findings in patients with Hb^ 10 and low folate vs. 
Hb> 10 and low folate. 
Finding Hb < 10 Hb> 10 Statistical 
Significance 
OBS 9/12 8/12 N.S. 
(757.) (66.77.) 






Neuropathy 6/12 8/12 N.S. 
( 507.) (66.7%) 
Babinski 2/12 3/12 N.S. 
(16.7% ) (257,) 
- 
TABLE 4: Comparison of findings in alcoholic patients with low folate vs. 








OBS and Psychiatric 8/12 3/8 N.S. 
Disorders 
(66.7%) (37.57c) 
Cerebellar 3/12 1/8 N.S. 
Dys function 
(257o ) (12.57c) 
Neuropathy 10/12 4/8 N.S. 
(83.37o) (507o ) 
| 







TABLE 5: Comparison of findings in non-alcoholic patients with low 
folate vs. non-alcoholics with normal folate 
Finding Low Normal Statistical 
Folate Folate Significance 
OBS and Psychiatric 9/12 5/13 A2 = 3.45 
Disorders 
(75%) (38.57,) p <.07 
Cerebellar 0/12 0/13 N.S. 
Dys function 
(0%) (0%) 
Neuropathy 4/12 3/13 n6s0 
(33.37c) (23.17c) 
Babinski 4/12 0/13 7S2 = 5.26 
(33.37c) (0%) p <.025 

TABLE 6: Comparison of Findings in alcoholic patients with low 
folate vs non-alcoholics with low folate 
Finding Alcoholic Non-alcoholic Statistical 
Significance 
OBS and Psychiatric 8/12 9/12 N.S. 
Disorders 
(66.7%) (75%) 
Cerebellar 3/12 0/12 *2 = 3.42 
Dysfunction 
(25%) ( 0%) p <. 07 
Neuropathy 10/12 4/12 X2 = 6.18 
(83.3%) (33.3%) p < . 014 
Babinski 1/12 4/12 NeS. 
(8.3%) (33.3%) 

TABLE 7: Comparison of Patients with Diseases not Usually 





Pneumonia 50 440 N1 
Phlebitis 50 950 OBS 
Ulcerative Colitis 50 545 Neuropathy 
Cancer Prostate Neuropathy 
(non-metastatic) 71 - OBS 
Pul. DlS. 77 440 Babinski 
Av g. 59.6 
NORMAL FOLATE 
Diagnosis Age ~^t2 
Findings 
Fe Deficiency 70 850 Depression 
Malabsorption 50 360 Neuropathy 
Malabsorption 56 - Depression 
Amebic Dyssentery 67 340 N1 
Cancer Pancreas 52 1200 N1 
Ulcer 55 320 N1 
Anemia 30 200 N1 
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